Susquehanna International Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-56,600
| Closed | -$492K | – | 10864 |
|
|
2018
Q2 | $492K | Buy |
56,600
+46,200
| +444% | +$416K | ﹤0.01% | 6821 |
|
|
2018
Q1 | $106K | Buy |
+10,400
| New | +$87.4K | ﹤0.01% | 8679 |
|
|
2017
Q2 | – | Sell |
-62,700
| Closed | -$298K | – | 10244 |
|
|
2017
Q1 | $298K | Buy |
+62,700
| New | +$317K | ﹤0.01% | 7347 |
|
|
2016
Q4 | – | Sell |
-15,900
| Closed | -$88K | – | 10483 |
|
|
2016
Q3 | $88K | Buy |
+15,900
| New | +$105K | ﹤0.01% | 7991 |
|
|
2015
Q4 | – | Sell |
-56,300
| Closed | -$663K | – | 10323 |
|
|
2015
Q3 | $663K | Buy |
56,300
+9,700
| +21% | +$107K | ﹤0.01% | 6575 |
|
|
2015
Q2 | $426K | Sell |
46,600
-5,400
| -10% | -$40.8K | ﹤0.01% | 7928 |
|
|
2015
Q1 | $323K | Buy |
+52,000
| New | +$322K | ﹤0.01% | 7851 |
|
|
2014
Q4 | – | Sell |
-26,500
| Closed | -$156K | – | 10366 |
|
|
2014
Q3 | $156K | Buy |
26,500
+15,200
| +135% | +$92.7K | ﹤0.01% | 8862 |
|
|
2014
Q2 | $77K | Buy |
+11,300
| New | +$75.6K | ﹤0.01% | 9507 |
|
|
2014
Q1 | – | Sell |
-16,900
| Closed | -$112K | – | 9689 |
|
|
2013
Q4 | $112K | Sell |
16,900
-38,700
| -70% | -$264K | ﹤0.01% | 8591 |
|
|
2013
Q3 | $404K | Buy |
+55,600
| New | +$374K | ﹤0.01% | 6757 |
|
Susquehanna International Group's JNP Position: Q3 2018 in Review
Susquehanna International Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 32,450 shares — an estimated $282K sold.
Susquehanna International Group first reported a position in JNP in Q1 2015 and held it in 9 quarters. The position peaked at $686K in Q3 2015. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Susquehanna International Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Susquehanna International Group sold 32,450 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $282K.
- Susquehanna International Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
- Susquehanna International Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $686K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.